Differences between target and implanted intraocular lens (IOL) power in Ethiopian cataract outreach campaigns were evaluated and machine learning (ML) applied to optimize IOL inventory and minimize avoidable refractive error. Patients from Ethiopian cataract campaigns with available target and implanted IOL records were identified and the diopter difference between the two measured. A gradient descent (an ML algorithm) was used to generate an optimal IOL inventory and measured the model's performance across varying surplus levels.Only 45.6% of patients received their target IOL power and 23.6% received underpowered IOLs with current inventory (50% surplus). The ML-generated IOL inventory ensured that >99.5% of patients received their target IOL when using only 39% IOL surplus.In Ethiopian cataract campaigns, the majority of patients have avoidable postoperative refractive error secondary to suboptimal IOL inventory. Optimizing IOL inventory using our ML model might eliminate refractive error from insufficient inventory and reduce costs.
To compare the postoperative outcomes between femtosecond laser-assisted cataract surgery (FLACS) and conventional phacoemulsification in eyes with shallow anterior chamber depth (ACD).
Eye Clinic, NEUROFARBA Department, University of Florence, Italy.
Prospective case series.
Forty eyes of 40 patients with senile cataract and true ACD less than 2.00 mm underwent FLACS (femto group, n = 20) or manual phacoemulsification (phacoemulsification group, n = 20). Preoperatively and 1 week and 1 month and 6 months postoperatively, central corneal thickness (CCT) and endothelial cell density were evaluated; basal epithelial cell (BEC) and Langerhans dendritic cell (LDC) densities and keratocyte activation were assessed using in vivo corneal confocal microscopy. Intraoperative parameters such as cumulative dissipated energy (CDE) and ultrasound (US) power were recorded.
Endothelial cell loss (ECL) was significantly lower in the femto group at all timepoints (P ≤ .001). In the phacoemulsification group, the CCT was significantly higher 1 week (P < .001) and 1 month (P < .001) postoperatively than preoperatively; conversely, in the femto group, it was higher only after 1 week (P < .001). **** and LDCs significantly increased at 1 postoperative week (P < .001), returning to preoperative values after 1 month in both groups. Keratocyte activation remained significantly higher at 1 postoperative month only in the phacoemulsification group (P = .005). CDE and US power were lower in the femto group (P = .017 and P = .001, respectively); they were correlated with ECL (r = 0.662, P = .000; r = 0.389, P = .013).
In eyes with shallow ACD, FLACS was a safe and an effective technique, significantly reducing the postoperative ECL and corneal inflammation compared with conventional phacoemulsification.
In eyes with shallow ACD, FLACS was a safe and an effective technique, significantly reducing the postoperative ECL and corneal inflammation compared with conventional phacoemulsification.
To evaluate the effectiveness and safety of 2 enhanced monofocal intraocular lenses (IOLs). The TECNIS Eyhance IOL(Model ICB00) was compared with a standard monofocal IOL (TECNIS monofocal, Model ZCB00).
European multicenter study.
Prospective, bilateral, randomized, comparative/evaluator-masked, controlled study.
Adult subjects scheduled to undergo bilateral, primary phacoemulsification cataract extraction and posterior IOL implantation were randomized to receive the enhanced monofocal ICB00 IOL or the ZCB00 monofocal IOL in both eyes. Monocular endpoints at 6 months included distance corrected intermediate visual acuity (DCIVA), photopic corrected distance visual acuity (CDVA), and uncorrected intermediate visual acuity (UCIVA). Binocular visual acuities, monocular corrected distance contrast sensitivity (first eyes), patient-reported outcomes, and safety were assessed at 6 months.
Overall, 139 patients were bilaterally implanted with the enhanced monofocal IOL (n = 67) or standard monofocal IOL (n = 72) and available for the 6-month visit. The enhanced monofocal IOL significantly improved mean monocular and binocular DCIVA and UCIVA by at least 1-line logMAR vs the standard monofocal IOL (all P ≤ .0001). Distance vision for the enhanced monofocal IOL was 20/20 or better and comparable to that of the standard monofocal lens at 6 months. Contrast sensitivity, photic phenomena outcomes, and rates of adverse events were similar between the 2 groups.
In patients undergoing cataract surgery, TECNIS Eyhance IOL Model ICB00 provided enhanced intermediate vision and similar distance performance and photic phenomena compared with a standard monofocal IOL, along with improved functional performance in daily life.
In patients undergoing cataract surgery, TECNIS Eyhance IOL Model ICB00 provided enhanced intermediate vision and similar distance performance and photic phenomena compared with a standard monofocal IOL, along with improved functional performance in daily life.
To evaluate and compare the predictability of intraocular lens (IOL) power calculation after small-incision lenticule extraction (SMILE) for myopia and myopic astigmatism.
Department of Ophthalmology, Philipps University of Marburg, Marburg, Germany.
Retrospective comparative case series.
The study included 204 eyes that underwent SMILE. Preoperative evaluation included optical biometry using IOLMaster 500 and corneal tomography using Pentacam HR. The corneal tomography measurements were repeated at 3 months postoperatively. The change of spherical equivalent due to SMILE was calculated by the manifest refraction at corneal plane (SMILE-Dif). A theoretical model, involving the virtual implantation of the same IOL before and after SMILE, was used and the IOL power calculations were performed using ray-tracing (Okulix, Version 9.06), third- (Hoffer Q, Holladay-1, SRK/T) and fourth-generation formulas (Haigis-L, Haigis). The difference between the IOL-induced refractive error at corneal plane before and after SMILE (IOL-Dif) was compared to SMILE-Dif. The prediction error (PE) was calculated as the difference between SMILE-Dif-IOL-Dif.
The PE with ray tracing was -0.06±0.40 diopters (D), Haigis-L -0.39±0.62 D, Haigis 0.70±0.48 D, Hoffer Q 0.84±0.47 D, Holladay-1 1.21±0.51 D and SRK/T 1.46±0.54 D. The PE with ray tracing was significantly smaller compared with all formulas (P≤0.001). The PE variance with ray tracing was σ=0.159, being significantly more homogenous compared with all formulas (P≤0.011, F≥6.549). https://www.selleckchem.com/products/vbit-12.html Ray tracing resulted in an absolute PE ≤0.5 D in 81.9% of the cases, followed by Haigis-L (53.4%), Haigis (35.3%), Hoffer Q (25.5%), Holladay-1 (6.4%) and SRK/T (2.9%).
Ray-tracing was the most accurate approach for IOL power calculation after myopic SMILE.
Ray-tracing was the most accurate approach for IOL power calculation after myopic SMILE.
Differences between target and implanted intraocular lens (IOL) power in Ethiopian cataract outreach campaigns were evaluated and machine learning (ML) applied to optimize IOL inventory and minimize avoidable refractive error. Patients from Ethiopian cataract campaigns with available target and implanted IOL records were identified and the diopter difference between the two measured. A gradient descent (an ML algorithm) was used to generate an optimal IOL inventory and measured the model's performance across varying surplus levels.Only 45.6% of patients received their target IOL power and 23.6% received underpowered IOLs with current inventory (50% surplus). The ML-generated IOL inventory ensured that >99.5% of patients received their target IOL when using only 39% IOL surplus.In Ethiopian cataract campaigns, the majority of patients have avoidable postoperative refractive error secondary to suboptimal IOL inventory. Optimizing IOL inventory using our ML model might eliminate refractive error from insufficient inventory and reduce costs.
To compare the postoperative outcomes between femtosecond laser-assisted cataract surgery (FLACS) and conventional phacoemulsification in eyes with shallow anterior chamber depth (ACD).
Eye Clinic, NEUROFARBA Department, University of Florence, Italy.
Prospective case series.
Forty eyes of 40 patients with senile cataract and true ACD less than 2.00 mm underwent FLACS (femto group, n = 20) or manual phacoemulsification (phacoemulsification group, n = 20). Preoperatively and 1 week and 1 month and 6 months postoperatively, central corneal thickness (CCT) and endothelial cell density were evaluated; basal epithelial cell (BEC) and Langerhans dendritic cell (LDC) densities and keratocyte activation were assessed using in vivo corneal confocal microscopy. Intraoperative parameters such as cumulative dissipated energy (CDE) and ultrasound (US) power were recorded.
Endothelial cell loss (ECL) was significantly lower in the femto group at all timepoints (P ≤ .001). In the phacoemulsification group, the CCT was significantly higher 1 week (P < .001) and 1 month (P < .001) postoperatively than preoperatively; conversely, in the femto group, it was higher only after 1 week (P < .001). BECs and LDCs significantly increased at 1 postoperative week (P < .001), returning to preoperative values after 1 month in both groups. Keratocyte activation remained significantly higher at 1 postoperative month only in the phacoemulsification group (P = .005). CDE and US power were lower in the femto group (P = .017 and P = .001, respectively); they were correlated with ECL (r = 0.662, P = .000; r = 0.389, P = .013).
In eyes with shallow ACD, FLACS was a safe and an effective technique, significantly reducing the postoperative ECL and corneal inflammation compared with conventional phacoemulsification.
In eyes with shallow ACD, FLACS was a safe and an effective technique, significantly reducing the postoperative ECL and corneal inflammation compared with conventional phacoemulsification.
To evaluate the effectiveness and safety of 2 enhanced monofocal intraocular lenses (IOLs). The TECNIS Eyhance IOL(Model ICB00) was compared with a standard monofocal IOL (TECNIS monofocal, Model ZCB00).
European multicenter study.
Prospective, bilateral, randomized, comparative/evaluator-masked, controlled study.
Adult subjects scheduled to undergo bilateral, primary phacoemulsification cataract extraction and posterior IOL implantation were randomized to receive the enhanced monofocal ICB00 IOL or the ZCB00 monofocal IOL in both eyes. Monocular endpoints at 6 months included distance corrected intermediate visual acuity (DCIVA), photopic corrected distance visual acuity (CDVA), and uncorrected intermediate visual acuity (UCIVA). Binocular visual acuities, monocular corrected distance contrast sensitivity (first eyes), patient-reported outcomes, and safety were assessed at 6 months.
Overall, 139 patients were bilaterally implanted with the enhanced monofocal IOL (n = 67) or standard monofocal IOL (n = 72) and available for the 6-month visit. The enhanced monofocal IOL significantly improved mean monocular and binocular DCIVA and UCIVA by at least 1-line logMAR vs the standard monofocal IOL (all P ≤ .0001). Distance vision for the enhanced monofocal IOL was 20/20 or better and comparable to that of the standard monofocal lens at 6 months. Contrast sensitivity, photic phenomena outcomes, and rates of adverse events were similar between the 2 groups.
In patients undergoing cataract surgery, TECNIS Eyhance IOL Model ICB00 provided enhanced intermediate vision and similar distance performance and photic phenomena compared with a standard monofocal IOL, along with improved functional performance in daily life.
In patients undergoing cataract surgery, TECNIS Eyhance IOL Model ICB00 provided enhanced intermediate vision and similar distance performance and photic phenomena compared with a standard monofocal IOL, along with improved functional performance in daily life.
To evaluate and compare the predictability of intraocular lens (IOL) power calculation after small-incision lenticule extraction (SMILE) for myopia and myopic astigmatism.
Department of Ophthalmology, Philipps University of Marburg, Marburg, Germany.
Retrospective comparative case series.
The study included 204 eyes that underwent SMILE. Preoperative evaluation included optical biometry using IOLMaster 500 and corneal tomography using Pentacam HR. The corneal tomography measurements were repeated at 3 months postoperatively. The change of spherical equivalent due to SMILE was calculated by the manifest refraction at corneal plane (SMILE-Dif). A theoretical model, involving the virtual implantation of the same IOL before and after SMILE, was used and the IOL power calculations were performed using ray-tracing (Okulix, Version 9.06), third- (Hoffer Q, Holladay-1, SRK/T) and fourth-generation formulas (Haigis-L, Haigis). The difference between the IOL-induced refractive error at corneal plane before and after SMILE (IOL-Dif) was compared to SMILE-Dif. The prediction error (PE) was calculated as the difference between SMILE-Dif-IOL-Dif.
The PE with ray tracing was -0.06±0.40 diopters (D), Haigis-L -0.39±0.62 D, Haigis 0.70±0.48 D, Hoffer Q 0.84±0.47 D, Holladay-1 1.21±0.51 D and SRK/T 1.46±0.54 D. The PE with ray tracing was significantly smaller compared with all formulas (P≤0.001). The PE variance with ray tracing was σ=0.159, being significantly more homogenous compared with all formulas (P≤0.011, F≥6.549). https://www.selleckchem.com/products/vbit-12.html Ray tracing resulted in an absolute PE ≤0.5 D in 81.9% of the cases, followed by Haigis-L (53.4%), Haigis (35.3%), Hoffer Q (25.5%), Holladay-1 (6.4%) and SRK/T (2.9%).
Ray-tracing was the most accurate approach for IOL power calculation after myopic SMILE.
Ray-tracing was the most accurate approach for IOL power calculation after myopic SMILE.
0 التعليقات
0 المشاركات
36 مشاهدة
0 معاينة
